a. Pallor and thrombosis
b. Kidney failure and fever
c. Fatigue, infection, and bleeding
d. Weakness, hemolysis, and infection
c. Fatigue, infection, and bleeding
a. Drug reaction
b. Benzene exposure
c. Inherited mutation in stem cells
d. Unknown cause
d. Unknown cause
a. Replacement of bone marrow cells by
abnormal cells
b. Destruction of stem cells by autoimmune T cells
c. Defective production of hematopoietic
growth factors
d. Inability of bone marrow stroma to support stem cells
b. Destruction of stem cells by
autoimmune T cells
a. Nonsevere
b. Moderate
c. Severe
d. Very severe
d. Very severe
a. Hairy cells, monocytopenia, and
neutropenia
b. Macrocytosis, thrombocytopenia, and
neutropenia
c. Blasts, immature granulocytes, and
thrombocytopenia
d. Polychromasia, nucleated RBCs, and
hypersegmented neutrophils
b. Macrocytosis, thrombocytopenia, and
neutropenia
a. Immunosuppressive therapy
b. Long-term red blood cell and platelet
transfusions
c. Administration of hematopoietic growth
factors and androgens
d. Bone marrow transplant with an
HLA-identical sibling
d. Bone marrow transplant with an
HLA-identical sibling
a. Bone marrow biopsy
b. Ham acidified serum test
c. Diepoxybutane-induced chromosome
breakage
d. Flow cytometric analysis of CD55 and
CD59 cells
c. Diepoxybutane-induced chromosome
breakage
a. Resistance of stem cells to normal
apoptosis
b. Autoimmune reaction against telomeres in stem cells
c. Decreased production of hematopoietic
growth factors
d. Premature death of hematopoietic
stem cells
d. Premature death of hematopoietic
stem cells
a. Reticulocyte count is increased
b. Fetal hemoglobin is decreased
c. Only erythropoiesis is affected
d. Congenital malformations are absent
c. Only erythropoiesis is affected
a. Fanconi anemia
b. Dyskeratosis congenita
c. Acquired aplastic anemia
d. Congenital dyserythropoietic anemia
d. Congenital dyserythropoietic anemia
a. Extracellular
b. Macrophage mediated
c. Intra-organ
d. Extrahematopoietic
b. Macrophage mediated
a. Hemoglobinuria
b. Hemosiderinuria
c. Hemoglobinemia
d. Elevated urinary urobilinogen level
d. Elevated urinary urobilinogen level
a. Inadequate production of
erythropoietin
b. Excessive hemolysis
c. Hematopoietic stem cell mutation
d. Toxic destruction of stem cells
a. Inadequate production of
erythropoietin
a. Reticulocytosis
b. Teardrop RBCs
c. Extramedullary hematopoiesis
d. Leukoerythroblastic blood picture
a. Reticulocytosis
a. Increased destruction of RBCs in the
blood, bone marrow, or spleen
b. Excessive loss of RBCs from the body
c. Inadequate RBC production by the bone
marrow
d. Increased plasma volume with unchanged red cell mass
a. Increased destruction of RBCs in the
blood, bone marrow, or spleen
a. Pallor
b. Yellow skin and eyes
c. Need for naps
d. Tiredness on exertion
b. Yellow skin and eyes
a. The decline in hemoglobin is too gradual
to be associated with hemolysis.
b. The elevation of the reticulocyte count
suggests a malignant cause.
c. Evidence of increased protoporphyrin
catabolism is lacking.
d. Elevated RDW points to an anemia of
decreased production.
c. Evidence of increased protoporphyrin
catabolism is lacking.
a. Urine urobilinogen level
b. Hemosiderin level
c. Reticulocyte count
d. Glycated hemoglobin level
c. Reticulocyte count
a. Acquired, fragmentation
b. Acquired, macrophage mediated
c. Hereditary, fragmentation
d. Hereditary, macrophage mediated
a. Acquired, fragmentation
a. Elevated total and indirect serum bilirubin
b. Elevated urinary urobilinogen
c. Decreased haptoglobin
d. Spherocytes on the peripheral blood
film
d. Spherocytes on the peripheral blood
film
a. Unconjugated bilirubin secreted by in the
liver
b. Urobilinogen reabsorbed from the
intestines
c. Macrophage-secreted indirect bilirubin
d. Direct bilirubin conjugated by hepatocytes
c. Macrophage-secreted indirect bilirubin
a. Increased Positive Positive
b. Decreased Negative Negative
c. Decreased Positive Positive
d. Increased Positive Negative
c. Decreased Positive Positive
a. Decreased osmotic fragility, negative DAT
result
b. Decreased osmotic fragility, positive DAT
result
c. Increased osmotic fragility, negative
DAT result
d. Increased osmotic fragility, positive DAT
result
c. Increased osmotic fragility, negative
DAT result
a. Decreased MCH
b. Decreased platelet and WBC counts
c. Increased MCHC
d. Increased MCV
c. Increased MCHC